|
| | Publication Year | Title | Author(s) |
| 21 | Nov-2017 | Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised,
double-blind, placebo-controlled, phase 3 trial. | Catenacci, Daniel V T; Tebbutt, Niall C ; Davidenko, Irina; Murad, André M; Al-Batran, Salah-Eddin; Ilson, David H; Tjulandin, Sergei; Gotovkin, Evengy; Karaszewska, Boguslawa; Bondarenko, Igor; Tejani, Mohamedtaki A; Udrea, Anghel A; Tehfe, Mustapha; De Vita, Ferdinando; Turkington, Cheryl; Tang, Rui; Ang, Agnes; Zhang, Yilong; Hoang, Tien; Sidhu, Roger; Cunningham, David |
| 22 | 30-Oct-2017 | SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial. | Jefford, Michael; Emery, Jon; Grunfeld, Eva; Martin, Andrew; Rodger, Paula; Murray, Alexandra M; De Abreu Lourenco, Richard; Heriot, Alexander; Phipps-Nelson, Jo; Guccione, Lisa; King, Dorothy; Lisy, Karolina; Tebbutt, Niall C ; Burgess, Adele N ; Faragher, Ian; Woods, Rodney; Schofield, Penelope |
| 23 | 24-Oct-2017 | The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. | Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M; Raraty, Michael; Jackson, Richard; Melling, James; Jones, Owain; Palmer, Daniel H; Cox, Trevor F; Smith, Chloe J; O'Reilly, Derek A; Izbicki, Jakob R; Scarfe, Andrew G; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David; Padbury, Robert; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Anthoney, Alan; Lerch, Markus M; Mayerle, Julia; Oláh, Attila; Rawcliffe, Charlotte L; Campbell, Fiona; Strobel, Oliver; Büchler, Markus W; Neoptolemos, John P |
| 24 | Sep-2017 | K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. | Yeung, Yvonne; Lau, David K ; Chionh, Fiona; Tran, Hoanh; Tse, Janson W T; Weickhardt, Andrew J ; Nikfarjam, Mehrdad ; Scott, Andrew M ; Tebbutt, Niall C ; Mariadason, John M |
| 25 | 28-Jul-2017 | Oral versus intravenous fluoropyrimidines for colorectal cancer | Chionh, Fiona; Lau, David; Yeung, Yvonne; Price, Timothy; Tebbutt, Niall C |
| 26 | 10-Jun-2017 | Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. | Renfro, Lindsay A; Goldberg, Richard M; Grothey, Axel; Sobrero, Alberto; Adams, Richard A; Seymour, Matthew T; Heinemann, Volker; Schmoll, Hans-Joachim; Douillard, Jean-Yves; Hurwitz, Herbert; Fuchs, Charles S; Diaz-Rubio, Eduardo; Porschen, Rainer; Tournigand, Christophe; Chibaudel, Benoist; Hoff, Paulo M; Kabbinavar, Fairooz F; Falcone, Alfredo; Tebbutt, Niall C ; Punt, Cornelis J A; Hecht, J Randolph; Souglakos, John; Bokemeyer, Carsten; Van Cutsem, Eric; Saltz, Leonard; de Gramont, Aimery; Sargent, Daniel J |
| 27 | Apr-2017 | Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer. | García-Carbonero, Rocío; van Cutsem, Eric; Rivera, Fernando; Jassem, Jacek; Gore, Ira; Tebbutt, Niall C ; Braiteh, Fadi; Argiles, Guillem; Wainberg, Zev A; Funke, Roel; Anderson, Maria; McCall, Bruce; Stroh, Mark; Wakshull, Eric; Hegde, Priti; Ye, Weilan; Chen, Daniel; Chang, Ilsung; Rhee, Ina; Hurwitz, Herbert |
| 28 | Oct-2016 | MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial | Gormly, Kirsten L; Coscia, Claudio; Wells, Tim; Tebbutt, Niall C ; Harvey, Jennifer A; Wilson, Kate; Schmoll, Hans-Joachim; Price, Timothy J |
| 29 | Sep-2016 | A randomized phase II study of FOLFOX with or without the MET inhibitor onartuzumab in advanced adenocarcinoma of the stomach and gastroesophageal junction | Shah, Manish A; Cho, Jae-Yong; Tan, Iain B; Tebbutt, Niall C ; Yen, Chia-Jui; Kang, Alice; Shames, David S; Bu, Lilian; Kang, Yoon-Koo |
| 30 | 10-Aug-2016 | Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): a multinational placebo-controlled phase II tria | Pavlakis, Nick; Sjoquist, Katrin M; Martin, Andrew J; Tsobanis, Eric; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Alcindor, Thierry; O’Callaghan, Christopher J; Burnell, Margot J; Tebbutt, Niall C ; Rha, Sun Young; Lee, Jeeyun; Cho, Jae-Yong; Lipton, Lara R; Wong, Mark; Strickland, Andrew; Kim, Jin Won; Zalcberg, John R; Simes, John; Goldstein, David |
| 31 | Aug-2016 | TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer. | Ferraro, D; Goldstein, D; O'Connell, R L; Zalcberg, J R; Sjoquist, K M; Tebbutt, Niall C ; Grimison, P; McLachlan, S; Lipton, L L; Vasey, P; Gebski, V J; Aiken, C; Cronk, M; Ng, S ; Karapetis, C S; Shannon, J |
| 32 | 15-May-2016 | Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer. | Liu, Geoffrey; Tu, Dongsheng; Lewis, Marcia; Cheng, Dangxiao; Sullivan, Leslie A; Chen, Zhuo; Morgen, Eric; Simes, John; Price, Timothy J; Tebbutt, Niall C ; Shapiro, Jeremy D; Jeffery, G Mark; Mellor, J Daniel; Mikeska, Thomas; Virk, Shakeel; Shepherd, Lois E; Jonker, Derek J; O'Callaghan, Christopher J ; Zalcberg, John R; Karapetis, Christos S; Dobrovic, Alexander |
| 33 | May-2016 | Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015. | Price, Timothy J; Thavaneswaran, Subotheni; Burge, Matthew; Segelov, Eva; Haller, Daniel G; Punt, Cornelis Ja; Arnold, Dirk; Karapetis, Christos S; Tebbutt, Niall C ; Pavlakis, Nick; Gibbs, Peter; Shapiro, Jeremy D |
| 34 | Mar-2016 | Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial | Tebbutt, Niall C ; Price, Timothy J; Ferraro, Danielle A; Wong, Nicole; Veillard, Anne-Sophie; Hall, Merryn; Sjoquist, Katrin M; Pavlakis, Nick; Strickland, Andrew; Varma, Suresh C; Cooray, Prasad; Young, Rosemary; Underhill, Craig; Shannon, Jennifer A; Ganju, Vinod; Gebski, Val J |
| 35 | 10-Jan-2016 | Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database. | Renfro, Lindsay A; Loupakis, Fotios; Adams, Richard A; Seymour, Matthew T; Heinemann, Volker; Schmoll, Hans-Joachim; Douillard, Jean-Yves; Hurwitz, Herbert; Fuchs, Charles S; Diaz-Rubio, Eduardo; Porschen, Rainer; Tournigand, Christophe; Chibaudel, Benoist; Falcone, Alfredo; Tebbutt, Niall C ; Punt, Cornelis J A; Hecht, J Randolph; Bokemeyer, Carsten; Van Cutsem, Eric; Goldberg, Richard M; Saltz, Leonard B; de Gramont, Aimery; Sargent, Daniel J; Lenz, Heinz-Josef |
| 36 | Jan-2016 | Symptom clusters in advanced cancer patients: an empirical comparison of statistical methods and the impact on quality of life | Dong, Skye T; Costa, Daniel SJ; Butow, Phyllis N; Lovell, Melanie R; Agar, Meera; Velikova, Galina; Teckle, Paulos; Tong, Allison; Tebbutt, Niall C ; Clarke, Stephen J; van der Hoek, Kim; King, Madeleine T; Fayers, Peter M |
| 37 | 14-Aug-2015 | Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. | Chan, David L; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva |
| 38 | 17-Mar-2015 | Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. | Price, Timothy J; Bruhn, M A; Lee, C K; Hardingham, J E; Townsend, A R; Mann, K P; Simes, J; Weickhardt, A ; Wrin, J W; Wilson, K; Gebski, V; Van Hazel, G; Robinson, B; Cunningham, D; Tebbutt, Niall C |
| 39 | 21-Nov-2014 | RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. | Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilić, Josipa; Cartón-García, Fernando; Nieto, Rocio; Suárez-López, Lucia; Afonso, Elsa; Landolfi, Stefania; Hernandez-Losa, Javier; Kobayashi, Kazuto; Cajal, Santiago Ramón Y; Tabernero, Josep; Tebbutt, Niall C ; Mariadason, John M ; Schwartz, Simo; Arango, Diego |
| 40 | 10-Nov-2014 | Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database. | Shi, Qian; de Gramont, Aimery; Grothey, Axel; Zalcberg, John; Chibaudel, Benoist; Schmoll, Hans-Joachim; Seymour, Matthew T; Adams, Richard A; Saltz, Leonard; Goldberg, Richard M; Punt, Cornelis J A; Douillard, Jean-Yves; Hoff, Paulo M; Hecht, Joel Randolph; Hurwitz, Herbert; Díaz-Rubio, Eduardo; Porschen, Rainer; Tebbutt, Niall C ; Fuchs, Charles; Souglakos, John; Falcone, Alfredo; Tournigand, Christophe; Kabbinavar, Fairooz F; Heinemann, Volker; Van Cutsem, Eric; Bokemeyer, Carsten; Buyse, Marc; Sargent, Daniel J |
Loading...
2
0
20
0
false